查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1801538

神经可塑性疗法市场报告：趋势、预测和竞争分析（至 2031 年）

Neuroplasticity Therapy Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球神经可塑性疗法市场前景光明，在慢性疼痛、双眼视觉、脑损伤治疗和其他领域都蕴藏着巨大的机会。预计2025年至2031年期间，全球神经可塑性疗法市场的复合年增长率将达到3.5%。这个市场的主要驱动因素包括：神经系统疾病盛行率的不断上升、基于神经可塑性疗法的不断进步、个人化脑损伤和復健治疗的日益普及，以及对早期疗育和预防的重视。

  • Lucintel 预测，功能性神经可塑性将在预测期内实现高速成长。
  • 透过应用，脑损伤治疗预计将实现高速成长。
  • 按地区划分，预计亚太地区将在预测期内实现最高成长。

神经可塑性治疗市场的新趋势

在技​​术创新和患者对个人化治疗日益增长的需求的推动下，神经可塑性治疗市场正在快速发展。关键趋势包括脑刺激技术的进步、人工智慧的融合以及数位治疗方法的兴起，所有这些都正在重塑认知復健的模式。

  • 脑刺激技术：经颅磁刺激 (TMS) 和经颅直流电刺激 (tDCS) 等非侵入性技术在刺激脑区和增强神经可塑性方面日益受到关注。这些技术在中风復健、忧郁症治疗和认知障碍领域的应用日益广泛。
  • 人工智慧驱动的神经可塑性解决方案：人工智慧正被用于透过分析大脑活动和患者数据来创建个人化治疗通讯协定。人工智慧解决方案能够实现更精准、更适应性的治疗，优化復健过程并改善临床疗效。
  • 数位疗法和行动应用程式：包括行动应用程式和基于虚拟实境 (VR) 的程式在内的数位疗法正在彻底改变神经可塑性疗法，让患者能够在家中进行认知练习。这些平台使治疗更易于获得、更具成本效益且扩充性，尤其是在医疗资源匮乏的地区。
  • 虚拟实境 (VR) 整合：VR 技术正被整合到神经可塑性疗法中，尤其针对中风和创伤性脑损伤 (TBI) 患者。 VR 復健计画让患者沉浸在模拟环境中，挑战认知和运动技能，进而改善神经可塑性治疗效果。
  • 重视早期疗育和预防：基于神经可塑性治疗方法的早期疗育和预防性照护日益受到重视，尤其是在阿兹海默症和帕金森氏症等神经退化性疾病中。早期治疗方法旨在增强脑功能，减缓这些疾病的进展，并改善患者的长期预后。

这些新兴趋势正在改变神经可塑性疗法市场，为各种神经系统疾病提供更便利、个人化且有效的治疗方案。脑刺激、人工智慧、虚拟实境和数位疗法的结合，正在引领更全面的认知復健方法，为患者提供多种復健途径。此外，对早期疗育和预防的日益重视，有望使神经可塑性疗法成为主流医学的重要组成部分，并在未来几年显着拓展市场。

神经可塑性治疗市场的最新趋势

由于技术、临床应用和法律规范的重大发展，神经可塑性治疗市场正在快速发展。关键发展包括人工智慧主导疗法的整合、脑刺激技术的日益普及以及认知復健数位平台的兴起。

  • 人工智慧主导的个人化治疗通讯协定：人工智慧正被用于根据患者的个别需求客製化神经可塑性疗法，并优化治疗效果。透过分析大脑活动、认知测试和患者数据，人工智慧可以实现更有针对性的治疗，从而缩短復原时间并改善大脑功能。
  • 不断扩展的脑刺激技术：经颅磁刺激 (TMS) 和经颅直流电刺激 (tDCS) 等非侵入性脑刺激技术正日益被用于治疗各种神经系统疾病，从中风復健到情绪障碍。这些治疗方法刺激特定的大脑区域，以增强神经连接并促进康復。
  • 认知復健数位平台的兴起：行动应用程式和虚拟实境在认知復健领域的应用正在迅速扩展。这些数位工具使神经可塑性疗法更加便利、经济高效，尤其对于偏远地区或无法接受现场治疗的患者而言。
  • 合作研发：学术机构、科技公司和医疗保健机构之间日益密切的合作正在加速创新神经可塑性疗法的开发。这些伙伴关係正在推动神经復健领域的突破，并促进促进大脑復健的治疗方法的研发。
  • 新型治疗方法获得监管核准：多种新型神经可塑性疗法已在多个地区获得监管部门核准，扩大了创新治疗方法的可及性。监管机构日益认可非侵入性治疗方法的有效性，为其在临床环境中的广泛应用铺平了道路。

这些发展显着加速了神经可塑性治疗市场的成长，并提高了治疗的可及性、个人化和有效性。人工智慧、数位平台和先进的脑刺激技术的应用，使得治疗更具针对性，缩短了復原时间，并扩大了可治疗疾病的范围。随着这些治疗方法获得更广泛的监管认可，市场有望进一步成长，将神经可塑性干预措施引入主流医学。

目录

第一章执行摘要

第二章 市场概述

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 宏观经济趋势与预测
  • 产业驱动力与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

第四章。全球神经可塑性治疗市场（按类型）

  • 概述
  • 吸引力分析：按类型
  • 结构神经可塑性：趋势与预测（2019-2031）
  • 功能神经可塑性：趋势与预测（2019-2031）

5. 全球神经可塑性治疗市场（按应用）

  • 概述
  • 吸引力分析：按用途
  • 慢性疼痛：趋势与预测（2019-2031）
  • 双眼视觉：趋势与预测（2019-2031）
  • 脑损伤治疗：趋势与预测（2019-2031）
  • 其他：趋势与预测（2019-2031）

第六章区域分析

  • 概述
  • 全球神经可塑性治疗市场（按地区）

7. 北美神经可塑性治疗市场

  • 概述
  • 美国神经可塑性治疗市场
  • 墨西哥的神经可塑性治疗市场
  • 加拿大神经可塑性治疗市场

8. 欧洲神经可塑性治疗市场

  • 概述
  • 德国神经可塑性治疗市场
  • 法国神经可塑性治疗市场
  • 西班牙神经可塑性治疗市场
  • 义大利神经可塑性治疗市场
  • 英国神经可塑性治疗市场

9. 亚太神经可塑性治疗市场

  • 概述
  • 日本神经可塑性治疗市场
  • 印度神经可塑性治疗市场
  • 中国的神经可塑性治疗市场
  • 韩国神经可塑性治疗市场
  • 印尼神经可塑性治疗市场

10. 世界其他地区（ROW）神经可塑性治疗市场

  • 概述
  • 中东神经可塑性治疗市场
  • 南美洲神经可塑性治疗市场
  • 非洲神经可塑性治疗市场

第十一章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市场占有率分析

第十二章机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 按应用分類的成长机会
  • 全球神经可塑性治疗市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 企业合併（M&A）、协议、合作与合资企业

第十三章 价值链主要企业概况

  • 竞争分析
  • Bionik
  • Mindmed
  • Nans Tech
  • Sense Therapy
  • IBT

第十四章 附录

  • 图片列表
  • 表格列表
  • 分析方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global neuroplasticity therapy market looks promising with opportunities in the chronic pain, binocular vision, treatment of brain damage, and other markets. The global neuroplasticity therapy market is expected to grow with a CAGR of 3.5% from 2025 to 2031. The major drivers for this market are the growing prevalence of neurological disorders and advancements in neuroplasticity-based therapies, the increasing adoption of personalized treatments for brain injury and rehabilitation, and the focus on early intervention and prevention.

  • Lucintel forecasts that, within the type category, functional neuroplasticity is expected to witness higher growth over the forecast period.
  • Within the application category, treatment of brain damage is expected to witness the higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Neuroplasticity Therapy Market

The neuroplasticity therapy market is evolving rapidly, driven by technological innovation and growing patient demand for personalized treatments. Key trends include advancements in brain stimulation techniques, the integration of artificial intelligence, and the rise of digital therapeutics, all of which are reshaping the landscape of cognitive rehabilitation.

  • Brain Stimulation Technologies: Non-invasive techniques like transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) are gaining traction for their effectiveness in stimulating brain regions to enhance neuroplasticity. These techniques are increasingly used in stroke rehabilitation, depression treatment, and cognitive disorders.
  • AI-Powered Neuroplasticity Solutions: Artificial intelligence is being used to create personalized therapy protocols by analyzing brain activity and patient data. AI-driven solutions enable more precise and adaptive treatments, optimizing recovery processes and improving clinical outcomes.
  • Digital Therapeutics and Mobile Apps: Digital therapeutics, including mobile apps and VR-based programs, are revolutionizing neuroplasticity therapy by offering patients the ability to engage in cognitive exercises at home. These platforms make therapy more accessible, cost-effective, and scalable, especially in underserved regions.
  • Integration of Virtual Reality (VR): VR technologies are being integrated into neuroplasticity therapies, particularly for stroke and traumatic brain injury (TBI) patients. VR-based rehabilitation programs engage patients in simulated environments that challenge cognitive and motor skills, improving neuroplasticity outcomes.
  • Focus on Early Intervention and Prevention: There is a growing emphasis on early intervention and preventive care for neuroplasticity-based therapies, particularly in neurodegenerative diseases like Alzheimer's and Parkinson's. Early-stage therapies are designed to enhance brain function and slow the progression of these conditions, improving long-term patient outcomes.

These emerging trends are transforming the neuroplasticity therapy market by offering more accessible, personalized, and effective treatments for a wide range of neurological conditions. The combination of brain stimulation, AI, VR, and digital therapeutics is leading to a more holistic approach to cognitive rehabilitation, providing patients with multiple pathways for recovery. Additionally, the growing emphasis on early intervention and prevention is likely to significantly expand the market in the coming years, making neuroplasticity therapies a key part of mainstream healthcare.

Recent Developments in the Neuroplasticity Therapy Market

The neuroplasticity therapy market has been evolving rapidly with notable developments in technology, clinical applications, and regulatory frameworks. Key advances include the integration of AI-driven therapies, increased adoption of brain stimulation techniques, and the rise of digital platforms for cognitive rehabilitation.

  • AI-Driven Personalized Therapy Protocols: AI is being used to tailor neuroplasticity treatments to individual patient needs, optimizing therapeutic outcomes. By analyzing brain activity, cognitive tests, and patient data, AI enables more targeted therapy, reducing recovery time and improving brain function.
  • Expansion of Brain Stimulation Techniques: Non-invasive brain stimulation techniques like TMS and tDCS are being increasingly used to treat a wide range of neurological conditions, from stroke recovery to mood disorders. These therapies help promote neural connections and facilitate recovery by stimulating specific brain regions.
  • Rise of Digital Platforms for Cognitive Rehabilitation: The use of mobile apps and virtual reality programs for cognitive rehabilitation is growing rapidly. These digital tools are making neuroplasticity therapy more accessible, cost-effective, and convenient for patients, particularly in remote areas or those with limited access to in-person care.
  • Collaborative Research and Development: Increased collaboration between academic institutions, tech companies, and healthcare providers is accelerating the development of innovative neuroplasticity therapies. These partnerships are driving breakthroughs in neurorehabilitation and fostering the creation of new therapies that enhance brain recovery.
  • Regulatory Approvals for New Therapies: Several new neuroplasticity therapies have received regulatory approval in various regions, expanding the availability of innovative treatments. Regulatory agencies are increasingly recognizing the effectiveness of non-invasive therapies, paving the way for wider adoption in clinical settings.

These developments are significantly accelerating the growth of the neuroplasticity therapy market by improving the accessibility, personalization, and effectiveness of treatments. The use of AI, digital platforms, and advanced brain stimulation techniques is enabling more targeted therapies, reducing recovery time, and expanding the range of treatable conditions. As these therapies receive wider regulatory acceptance, the market is likely to see further growth, bringing neuroplasticity interventions to mainstream healthcare.

Strategic Growth Opportunities in the Neuroplasticity Therapy Market

The neuroplasticity therapy market presents numerous growth opportunities across a range of applications, particularly in cognitive rehabilitation, mental health, and neurodegenerative diseases. The rise of digital health technologies and the increasing demand for personalized treatments are opening new avenues for expansion.

  • Cognitive Rehabilitation for Stroke and TBI: There is significant growth potential in applying neuroplasticity therapies to stroke and traumatic brain injury (TBI) patients. Advanced therapies like VR and brain stimulation can accelerate recovery by promoting neural plasticity and restoring cognitive function.
  • Treatment for Neurodegenerative Diseases: Neuroplasticity therapies are being increasingly explored for conditions like Alzheimer's and Parkinson's disease. Early-stage interventions can improve brain function and slow disease progression, presenting a major opportunity in the growing geriatric care market.
  • Mental Health and Depression: Neuroplasticity therapies are also being used to treat mental health conditions such as depression, anxiety, and PTSD. By targeting specific brain regions, these therapies offer a non-pharmacological alternative, creating a growing market for mental health applications.
  • Mobile Applications for At-Home Therapy: Mobile and digital platforms that deliver neuroplasticity-based therapies at home present significant growth potential. These platforms are making therapy more accessible, scalable, and affordable, especially for patients who do not have access to in-person sessions.
  • Early Intervention in Pediatric Care: Neuroplasticity therapies are increasingly being used in early childhood to address developmental delays and cognitive impairments. This represents a growing market for therapies designed to enhance brain development and learning in young children.

These strategic growth opportunities are reshaping the neuroplasticity therapy market by expanding its reach to diverse patient populations and applications. From stroke recovery to mental health treatment and pediatric interventions, neuroplasticity therapies are becoming integral to modern healthcare. The rise of digital solutions and early-stage interventions is further broadening market access, making neuroplasticity therapies a more integral part of preventive and rehabilitative healthcare across the globe.

Neuroplasticity Therapy Market Driver and Challenges

The neuroplasticity therapy market is being driven by technological advancements, increased awareness of neurological disorders, and a growing demand for personalized, non-invasive treatments. However, challenges such as regulatory hurdles, high treatment costs, and the need for more clinical evidence remain significant obstacles to widespread adoption.

The factors responsible for driving the neuroplasticity therapy market include:

1. Technological Advancements in Brain Stimulation: New techniques in brain stimulation, such as TMS and tDCS, are allowing for more effective and targeted neuroplasticity therapies. These technologies have proven successful in treating a range of neurological conditions, from cognitive decline to mental health disorders.

2. Increasing Prevalence of Neurological Disorders: The rising incidence of neurological conditions like stroke, Alzheimer's, and Parkinson's is fueling demand for neuroplasticity therapies. As populations age, the need for effective rehabilitation and prevention treatments is growing, expanding the market.

3. Government and Private Funding: Increased investments in research and development, both from governments and private enterprises, are driving innovation in the neuroplasticity therapy space. Funding is helping accelerate the development of new therapies and solutions.

4. Growing Awareness and Acceptance of Non-Invasive Therapies: As patients and healthcare providers seek alternatives to invasive surgeries and medications, non-invasive neuroplasticity therapies are gaining acceptance. These therapies are seen as safer and more accessible options for long-term treatment.

5. Rising Demand for Personalized Medicine: The trend toward personalized medicine is boosting the adoption of neuroplasticity therapies. AI and data-driven solutions are being used to tailor therapies to individual patient needs, optimizing outcomes and improving recovery.

Challenges in the neuroplasticity therapy market are:

1. Regulatory Approval and Standardization: Regulatory hurdles remain a major challenge for new neuroplasticity therapies. Obtaining approvals for new treatments and establishing standard protocols for care are critical for market expansion and adoption.

2. High Treatment Costs: While neuroplasticity therapies are effective, their high costs can be prohibitive, particularly for patients in low-income regions. This limits market access and adoption, particularly in emerging economies.

3. Need for More Clinical Evidence: Despite growing interest, more rigorous clinical trials and evidence are needed to establish the long-term efficacy of many neuroplasticity therapies. The lack of robust clinical data may slow the acceptance and reimbursement of these therapies.

The neuroplasticity therapy market is experiencing rapid growth, driven by technological innovation, an aging population, and increasing demand for non-invasive treatments. While the market faces challenges related to regulatory approvals, cost, and clinical evidence, the potential for growth is substantial. The ongoing advancements in brain stimulation technologies, digital health, and personalized treatments are reshaping the landscape of cognitive rehabilitation, offering new hope for patients and expanding the market globally.

List of Neuroplasticity Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, neuroplasticity therapy companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neuroplasticity therapy companies profiled in this report include:

  • Bionik
  • Mindmed
  • Nans Tech
  • Sense Therapy
  • IBT

Neuroplasticity Therapy Market by Segment

The study includes a forecast for the global neuroplasticity therapy market by type, application, and region.

Neuroplasticity Therapy Market by Type [Value from 2019 to 2031]:

  • Structural Neuroplasticity
  • Functional Neuroplasticity

Neuroplasticity Therapy Market by Application [Value from 2019 to 2031]:

  • Chronic Pain
  • Binocular Vision
  • Treatment Of Brain Damage
  • Others

Neuroplasticity Therapy Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Neuroplasticity Therapy Market

The neuroplasticity therapy market has witnessed significant advancements in recent years, driven by a growing understanding of brain adaptability and the application of innovative therapies. Key regions such as the United States, China, Germany, India, and Japan have seen substantial developments in both research and clinical applications of neuroplasticity therapies. These advancements include the use of non-invasive techniques, AI, and digital platforms to enhance brain recovery and cognitive function, offering new hope for patients with neurological disorders.

  • United States: In the United States, the neuroplasticity therapy market is driven by ongoing clinical research and the integration of advanced technologies such as transcranial magnetic stimulation (TMS) and neurofeedback. The U.S. market has also seen significant growth in digital therapeutics, which offer at-home therapies for brain training. Public and private funding for neuroplasticity research, especially for post-stroke recovery and cognitive impairments, has increased, leading to the development of new therapies and more personalized treatment options for neurological patients.
  • China: China's neuroplasticity therapy market is expanding due to the country's significant investments in healthcare innovation and a growing focus on mental health. Non-invasive therapies like transcranial direct current stimulation (tDCS) and neurofeedback are being increasingly adopted for cognitive rehabilitation. In addition, China is leveraging AI and big data to develop personalized neuroplasticity therapy protocols. With a large aging population and a rising incidence of neurological diseases, the demand for neuroplasticity therapies is expected to continue growing.
  • Germany: Germany is at the forefront of neuroplasticity therapy development in Europe, with a strong emphasis on research and the integration of advanced technologies in clinical settings. Neurorehabilitation centers are adopting techniques such as robotic therapy and brain-computer interfaces (BCIs) to enhance neuroplasticity. The country's healthcare system supports innovation in non-invasive therapies, particularly for stroke recovery and dementia. Collaborative research between universities, tech companies, and healthcare providers is helping drive the growth of the market.
  • India: In India, the neuroplasticity therapy market is gaining momentum, particularly in urban centers where awareness of neurological disorders is on the rise. There is increasing adoption of cognitive rehabilitation therapies using VR, neurofeedback, and digital platforms. India is also seeing the rise of specialized clinics and startups offering neuroplasticity-based treatments for conditions such as stroke, Parkinson's disease, and developmental disorders. Affordability and access to these therapies remain challenges, but the demand for affordable neuroplasticity solutions is driving growth.
  • Japan: Japan is a leader in the development of neuroplasticity therapies, particularly for aging populations. The country has pioneered the use of brain stimulation techniques, such as tDCS and repetitive transcranial magnetic stimulation (rTMS), to treat cognitive decline and improve motor function in stroke and Alzheimer's patients. Japan's healthcare system has embraced technology-driven solutions, including AI-based brain training programs and robotic rehabilitation devices, to accelerate neuroplastic recovery, making neuroplasticity therapy more accessible and effective for patients.

Features of the Global Neuroplasticity Therapy Market

  • Market Size Estimates: Neuroplasticity therapy market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Neuroplasticity therapy market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Neuroplasticity therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the neuroplasticity therapy market.
  • Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the neuroplasticity therapy market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neuroplasticity therapy market by type (structural neuroplasticity and functional neuroplasticity), application (chronic pain, binocular vision, treatment of brain damage, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Neuroplasticity Therapy Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Structural Neuroplasticity: Trends and Forecast (2019-2031)
  • 4.4 Functional Neuroplasticity: Trends and Forecast (2019-2031)

5. Global Neuroplasticity Therapy Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Chronic Pain: Trends and Forecast (2019-2031)
  • 5.4 Binocular Vision: Trends and Forecast (2019-2031)
  • 5.5 Treatment of Brain Damage: Trends and Forecast (2019-2031)
  • 5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Neuroplasticity Therapy Market by Region

7. North American Neuroplasticity Therapy Market

  • 7.1 Overview
  • 7.4 United States Neuroplasticity Therapy Market
  • 7.5 Mexican Neuroplasticity Therapy Market
  • 7.6 Canadian Neuroplasticity Therapy Market

8. European Neuroplasticity Therapy Market

  • 8.1 Overview
  • 8.4 German Neuroplasticity Therapy Market
  • 8.5 French Neuroplasticity Therapy Market
  • 8.6 Spanish Neuroplasticity Therapy Market
  • 8.7 Italian Neuroplasticity Therapy Market
  • 8.8 United Kingdom Neuroplasticity Therapy Market

9. APAC Neuroplasticity Therapy Market

  • 9.1 Overview
  • 9.4 Japanese Neuroplasticity Therapy Market
  • 9.5 Indian Neuroplasticity Therapy Market
  • 9.6 Chinese Neuroplasticity Therapy Market
  • 9.7 South Korean Neuroplasticity Therapy Market
  • 9.8 Indonesian Neuroplasticity Therapy Market

10. ROW Neuroplasticity Therapy Market

  • 10.1 Overview
  • 10.4 Middle Eastern Neuroplasticity Therapy Market
  • 10.5 South American Neuroplasticity Therapy Market
  • 10.6 African Neuroplasticity Therapy Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Neuroplasticity Therapy Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Bionik
    • Company Overview
    • Neuroplasticity Therapy Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Mindmed
    • Company Overview
    • Neuroplasticity Therapy Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Nans Tech
    • Company Overview
    • Neuroplasticity Therapy Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Sense Therapy
    • Company Overview
    • Neuroplasticity Therapy Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 IBT
    • Company Overview
    • Neuroplasticity Therapy Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Neuroplasticity Therapy Market
  • Figure 2.1: Usage of Neuroplasticity Therapy Market
  • Figure 2.2: Classification of the Global Neuroplasticity Therapy Market
  • Figure 2.3: Supply Chain of the Global Neuroplasticity Therapy Market
  • Figure 2.4: Driver and Challenges of the Neuroplasticity Therapy Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 4.1: Global Neuroplasticity Therapy Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Neuroplasticity Therapy Market ($B) by Type
  • Figure 4.3: Forecast for the Global Neuroplasticity Therapy Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Structural Neuroplasticity in the Global Neuroplasticity Therapy Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Functional Neuroplasticity in the Global Neuroplasticity Therapy Market (2019-2031)
  • Figure 5.1: Global Neuroplasticity Therapy Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Neuroplasticity Therapy Market ($B) by Application
  • Figure 5.3: Forecast for the Global Neuroplasticity Therapy Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Chronic Pain in the Global Neuroplasticity Therapy Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Binocular Vision in the Global Neuroplasticity Therapy Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Treatment of Brain Damage in the Global Neuroplasticity Therapy Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Others in the Global Neuroplasticity Therapy Market (2019-2031)
  • Figure 6.1: Trends of the Global Neuroplasticity Therapy Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Neuroplasticity Therapy Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Neuroplasticity Therapy Market (2019-2031)
  • Figure 7.2: North American Neuroplasticity Therapy Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Neuroplasticity Therapy Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Neuroplasticity Therapy Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Neuroplasticity Therapy Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Neuroplasticity Therapy Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Neuroplasticity Therapy Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Neuroplasticity Therapy Market (2019-2031)
  • Figure 8.2: European Neuroplasticity Therapy Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Neuroplasticity Therapy Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Neuroplasticity Therapy Market ($B) by Type (2025-2031)
  • Figure 8.5: European Neuroplasticity Therapy Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Neuroplasticity Therapy Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Neuroplasticity Therapy Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Neuroplasticity Therapy Market (2019-2031)
  • Figure 9.2: APAC Neuroplasticity Therapy Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Neuroplasticity Therapy Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Neuroplasticity Therapy Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Neuroplasticity Therapy Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Neuroplasticity Therapy Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Neuroplasticity Therapy Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Neuroplasticity Therapy Market (2019-2031)
  • Figure 10.2: ROW Neuroplasticity Therapy Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Neuroplasticity Therapy Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Neuroplasticity Therapy Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Neuroplasticity Therapy Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Neuroplasticity Therapy Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Neuroplasticity Therapy Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Neuroplasticity Therapy Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Neuroplasticity Therapy Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Neuroplasticity Therapy Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Neuroplasticity Therapy Market by Type
  • Figure 12.2: Growth Opportunities for the Global Neuroplasticity Therapy Market by Application
  • Figure 12.3: Growth Opportunities for the Global Neuroplasticity Therapy Market by Region
  • Figure 12.4: Emerging Trends in the Global Neuroplasticity Therapy Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Neuroplasticity Therapy Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Neuroplasticity Therapy Market by Region
  • Table 1.3: Global Neuroplasticity Therapy Market Parameters and Attributes
  • Table 3.1: Trends of the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 3.2: Forecast for the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Neuroplasticity Therapy Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 4.4: Trends of Structural Neuroplasticity in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 4.5: Forecast for Structural Neuroplasticity in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 4.6: Trends of Functional Neuroplasticity in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 4.7: Forecast for Functional Neuroplasticity in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Neuroplasticity Therapy Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 5.4: Trends of Chronic Pain in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 5.5: Forecast for Chronic Pain in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 5.6: Trends of Binocular Vision in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 5.7: Forecast for Binocular Vision in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 5.8: Trends of Treatment of Brain Damage in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 5.9: Forecast for Treatment of Brain Damage in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 5.10: Trends of Others in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 5.11: Forecast for Others in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Neuroplasticity Therapy Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Neuroplasticity Therapy Market (2025-2031)
  • Table 7.1: Trends of the North American Neuroplasticity Therapy Market (2019-2024)
  • Table 7.2: Forecast for the North American Neuroplasticity Therapy Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Neuroplasticity Therapy Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Neuroplasticity Therapy Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Neuroplasticity Therapy Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Neuroplasticity Therapy Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Neuroplasticity Therapy Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Neuroplasticity Therapy Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Neuroplasticity Therapy Market (2019-2031)
  • Table 8.1: Trends of the European Neuroplasticity Therapy Market (2019-2024)
  • Table 8.2: Forecast for the European Neuroplasticity Therapy Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Neuroplasticity Therapy Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Neuroplasticity Therapy Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Neuroplasticity Therapy Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Neuroplasticity Therapy Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Neuroplasticity Therapy Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Neuroplasticity Therapy Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Neuroplasticity Therapy Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Neuroplasticity Therapy Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Neuroplasticity Therapy Market (2019-2031)
  • Table 9.1: Trends of the APAC Neuroplasticity Therapy Market (2019-2024)
  • Table 9.2: Forecast for the APAC Neuroplasticity Therapy Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Neuroplasticity Therapy Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Neuroplasticity Therapy Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Neuroplasticity Therapy Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Neuroplasticity Therapy Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Neuroplasticity Therapy Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Neuroplasticity Therapy Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Neuroplasticity Therapy Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Neuroplasticity Therapy Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Neuroplasticity Therapy Market (2019-2031)
  • Table 10.1: Trends of the ROW Neuroplasticity Therapy Market (2019-2024)
  • Table 10.2: Forecast for the ROW Neuroplasticity Therapy Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Neuroplasticity Therapy Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Neuroplasticity Therapy Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Neuroplasticity Therapy Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Neuroplasticity Therapy Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Neuroplasticity Therapy Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Neuroplasticity Therapy Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Neuroplasticity Therapy Market (2019-2031)
  • Table 11.1: Product Mapping of Neuroplasticity Therapy Suppliers Based on Segments
  • Table 11.2: Operational Integration of Neuroplasticity Therapy Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Neuroplasticity Therapy Revenue
  • Table 12.1: New Product Launches by Major Neuroplasticity Therapy Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Neuroplasticity Therapy Market